Personalised medicine

Personalised medicine is a high-value field, expected to expand significantly over the coming years. Strong IP strategy is key to successfully protecting emerging innovations that hold the potential to transform lives.  

The number of drug approvals in precision medicine is growing rapidly, yet this progress comes with significant legal and technical challenges. From navigating patent eligibility exclusions, to dealing with issues of ownership of data or divided infringement, while ensuring protection covers the constant evolution of assay platforms, good guidance is vital to success. 

Working with leading universities, research charities and pioneering SMEs, HGF’s large personalised medicine team delivers patent drafting and prosecution, due diligence and freedom to operate programmes, along with management of transactional and contentious matters in this revolutionary field.  

Our attorneys have a deep understanding of the challenges in this area.  With extensive in-house experience, we are able to tap into genuine insights to lead our clients’ IP strategies and advise across multiple jurisdictions. HGF’s perspective as European attorneys can help to identify global opportunities for clients from across the globe.

Latest updates

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 23rd March 2022

HGF webinar: Getting your first filing right

HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …

Event details

The Microbiome Times: ELIGO v SNIPR: a reflection on IP strategies in a competitive environment

HGF Partner and Patent Attorney Craig Thomson and Patent Director Dr Jennifer Bailey write an article for The Microbiome Times on ELIGO v SNIPR: a reflection on IP strategies in …

Read article

Getting your first filing right

One of the most often asked questions of patent attorneys is “when should we file?” Both timing and content of a first filing should be important strategic decisions. This is …

Read article

Start-ups & IP, a case study: SleepCogni

Using SleepCogni as a case study, we look at some key ways that IP can help start-ups to develop their technology and secure investment. SleepCogni is a SleepTech start-up who …

Read article
Event - 26th October 2021

9th Microbiome R&D and Business Collaboration Forum: Europe

9th Microbiome R&D and Business Collaboration Forum: Europe will be held on 26th-27th October 2021 in Rotterdam, The Netherlands. The event is dedicated to exploring microbiome research and strategies for …

Event details
Event - 21st October 2021

Medical Technology Ireland Conference 2021

Medical Technology Ireland Conference will be held on 20-21 October 2021 at the Galway Racecourse. Medical Technology Ireland Conference features presentations by leading international medical device experts with thought-provoking guest …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our personalised medicine specialists.